news
Scientists have shown that start codon disruption with CRISPR-Cas9 gene…
4 August 2021 | By Anna Begley (Drug Target Review)
Scientists have shown that start codon disruption with CRISPR-Cas9 gene editing can prevent Fuchs’ corneal dystrophy in mouse models.